Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant

Thomas J. Bassler, Roberto Orozco, Ilene C. Bassler, Gerard J. O’Dowd, Thomas A. Stamey

Open source

DOI
10.1016/s0090-4295(98)00366-5
Published
1998-12
Container
Urology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0090-4295-98-00366-5,
  title = {Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant},
  author = {Thomas J. Bassler and Roberto Orozco and Ilene C. Bassler and Gerard J. O’Dowd and Thomas A. Stamey},
  year = {1998},
  journal = {Urology},
  doi = {10.1016/s0090-4295(98)00366-5},
  url = {https://doi.org/10.1016/s0090-4295(98)00366-5}
}

RIS

TY  - JOUR
TI  - Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant
AU  - Thomas J. Bassler
AU  - Roberto Orozco
AU  - Ilene C. Bassler
AU  - Gerard J. O’Dowd
AU  - Thomas A. Stamey
PY  - 1998
JO  - Urology
DO  - 10.1016/s0090-4295(98)00366-5
UR  - https://doi.org/10.1016/s0090-4295(98)00366-5
ER  - 

APA

Bassler, T. J., Orozco, R., Bassler, I. C., O’Dowd, G. J., & Stamey, T. A. (1998). Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant. Urology. https://doi.org/10.1016/s0090-4295(98)00366-5

Source records